25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ANIK (Anika) Stock Analysis
Buy, Hold or Sell?

Let's analyze Anika together

I guess you are interested in Anika Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Anika’s Financial Insights
  • 📈 Technical Analysis (TA) – Anika’s Price Targets

I'm going to help you getting a better view of Anika Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Anika Therapeutics Inc

I send you an email if I find something interesting about Anika Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Anika (30 sec.)










1.2. What can you expect buying and holding a share of Anika? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$10.35
Expected worth in 1 year
$6.51
How sure are you?
52.5%

+ What do you gain per year?

Total Gains per Share
$-3.84
Return On Investment
-34.1%

For what price can you sell your share?

Current Price per Share
$11.25
Expected price per share
$10.47 - $12.83
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Anika (5 min.)




Live pricePrice per Share (EOD)
$11.25
Intrinsic Value Per Share
$-8.39 - $8.49
Total Value Per Share
$1.95 - $18.83

2.2. Growth of Anika (5 min.)




Is Anika growing?

Current yearPrevious yearGrowGrow %
How rich?$148.3m$241.3m-$68.1m-39.4%

How much money is Anika making?

Current yearPrevious yearGrowGrow %
Making money-$14.1m-$19.2m$5m35.4%
Net Profit Margin399.7%-44.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Anika (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Anika?

Welcome investor! Anika's management wants to use your money to grow the business. In return you get a share of Anika.

First you should know what it really means to hold a share of Anika. And how you can make/lose money.

Speculation

The Price per Share of Anika is $11.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Anika.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Anika, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $10.35. Based on the TTM, the Book Value Change Per Share is $-0.96 per quarter. Based on the YOY, the Book Value Change Per Share is $-1.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Anika.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.34-3.0%-0.96-8.6%-1.31-11.7%-0.89-7.9%-0.63-5.6%-0.08-0.7%
Usd Book Value Change Per Share-0.11-1.0%-0.96-8.5%-1.19-10.6%-0.78-7.0%-0.50-4.4%-0.04-0.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.11-1.0%-0.96-8.5%-1.19-10.6%-0.78-7.0%-0.50-4.4%-0.04-0.3%
Usd Price Per Share15.03-20.38-23.17-23.22-29.23-36.29-
Price to Earnings Ratio-11.06--271.17--16.79--102.79--48.95--14.87-
Price-to-Total Gains Ratio-132.96--512.08--71.66--608.05--343.88--138.96-
Price to Book Ratio1.45-1.71-1.44-1.50-1.68-2.19-
Price-to-Total Gains Ratio-132.96--512.08--71.66--608.05--343.88--138.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share11.25
Number of shares88
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.96-0.50
Usd Total Gains Per Share-0.96-0.50
Gains per Quarter (88 shares)-84.49-43.79
Gains per Year (88 shares)-337.97-175.16
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-338-3480-175-185
20-676-6860-350-360
30-1014-10240-525-535
40-1352-13620-701-710
50-1690-17000-876-885
60-2028-20380-1051-1060
70-2366-23760-1226-1235
80-2704-27140-1401-1410
90-3042-30520-1576-1585
100-3380-33900-1752-1760

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%3.017.00.015.0%22.018.00.055.0%80.047.01.062.5%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%21.019.00.052.5%79.047.02.061.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%1.00.0127.00.8%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%4.016.00.020.0%21.019.00.052.5%79.047.02.061.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Anika Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.113-0.960+749%-1.189+952%-0.784+594%-0.498+340%-0.038-67%
Book Value Per Share--10.34711.790-12%16.454-37%15.883-35%17.388-40%16.863-39%
Current Ratio--5.7265.469+5%5.7300%5.710+0%5.664+1%10.874-47%
Debt To Asset Ratio--0.2210.221+0%0.192+15%0.199+11%0.213+4%0.154+43%
Debt To Equity Ratio--0.2840.284+0%0.238+19%0.249+14%0.276+3%0.192+48%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--226714242.000309468343.000-27%352644627.500-36%355371003.500-36%440208428.700-48%599486912.756-62%
Eps---0.340-0.964+184%-1.311+286%-0.885+161%-0.631+86%-0.075-78%
Ev To Ebitda Ratio---21.0545.283-499%-308.628+1366%-86.546+311%-5.765-73%4.222-599%
Ev To Sales Ratio--2.166-10.350+578%2.084+4%-1.899+188%0.492+341%3.764-42%
Free Cash Flow Per Share---0.206-0.058-72%-0.070-66%-0.070-66%-0.003-98%0.222-193%
Free Cash Flow To Equity Per Share---0.585-0.330-44%-0.189-68%-0.233-60%-0.140-76%0.053-1204%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.000+0%
Intrinsic Value_10Y_max--8.486----------
Intrinsic Value_10Y_min---8.393----------
Intrinsic Value_1Y_max--0.883----------
Intrinsic Value_1Y_min---0.379----------
Intrinsic Value_3Y_max--2.628----------
Intrinsic Value_3Y_min---1.546----------
Intrinsic Value_5Y_max--4.343----------
Intrinsic Value_5Y_min---3.149----------
Market Cap161340750.000-34%215551242.000299625093.000-28%339868627.500-37%340381003.500-37%425412228.700-49%535034748.556-60%
Net Profit Margin---0.1863.997-105%-0.449+141%1.135-116%0.636-129%0.444-142%
Operating Margin---0.164-5.081+3004%-0.110-33%-1.790+993%-1.122+585%-0.383+134%
Operating Ratio--1.1646.612-82%1.107+5%2.967-61%2.234-48%1.440-19%
Pb Ratio1.087-34%1.4531.710-15%1.439+1%1.499-3%1.679-14%2.193-34%
Pe Ratio-8.277+25%-11.058-271.174+2352%-16.791+52%-102.790+830%-48.954+343%-14.874+35%
Price Per Share11.250-34%15.03020.380-26%23.168-35%23.219-35%29.230-49%36.288-59%
Price To Free Cash Flow Ratio-13.654+25%-18.24251.256-136%-0.007-100%23.932-176%33.230-155%37.023-149%
Price To Total Gains Ratio-99.520+25%-132.958-512.082+285%-71.662-46%-608.052+357%-343.876+159%-138.957+5%
Quick Ratio--4.2103.716+13%4.176+1%4.439-5%4.596-8%10.914-61%
Return On Assets---0.026-0.066+157%-0.070+172%-0.050+98%-0.034+33%-0.003-88%
Return On Equity---0.033-0.085+160%-0.088+169%-0.064+96%-0.044+33%-0.007-80%
Total Gains Per Share---0.113-0.960+749%-1.189+952%-0.784+594%-0.498+340%-0.038-67%
Usd Book Value--148397000.000173147000.000-14%241325500.000-39%232677583.333-36%253190900.000-41%247592966.550-40%
Usd Book Value Change Per Share---0.113-0.960+749%-1.189+952%-0.784+594%-0.498+340%-0.038-67%
Usd Book Value Per Share--10.34711.790-12%16.454-37%15.883-35%17.388-40%16.863-39%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--226714242.000309468343.000-27%352644627.500-36%355371003.500-36%440208428.700-48%599486912.756-62%
Usd Eps---0.340-0.964+184%-1.311+286%-0.885+161%-0.631+86%-0.075-78%
Usd Free Cash Flow---2954000.000-837750.000-72%-1035500.000-65%-1031833.333-65%-60400.000-98%3282104.650-190%
Usd Free Cash Flow Per Share---0.206-0.058-72%-0.070-66%-0.070-66%-0.003-98%0.222-193%
Usd Free Cash Flow To Equity Per Share---0.585-0.330-44%-0.189-68%-0.233-60%-0.140-76%0.053-1204%
Usd Market Cap161340750.000-34%215551242.000299625093.000-28%339868627.500-37%340381003.500-37%425412228.700-49%535034748.556-60%
Usd Price Per Share11.250-34%15.03020.380-26%23.168-35%23.219-35%29.230-49%36.288-59%
Usd Profit---4873000.000-14186000.000+191%-19207750.000+294%-12987583.333+167%-9221300.000+89%-1086164.450-78%
Usd Revenue--26168000.00026388000.000-1%42315250.000-38%36023333.333-27%35591350.000-26%31541670.450-17%
Usd Total Gains Per Share---0.113-0.960+749%-1.189+952%-0.784+594%-0.498+340%-0.038-67%
 EOD+3 -5MRQTTM+18 -19YOY+15 -223Y+18 -195Y+17 -2010Y+7 -31

3.3 Fundamental Score

Let's check the fundamental score of Anika Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.277
Price to Book Ratio (EOD)Between0-11.087
Net Profit Margin (MRQ)Greater than0-0.186
Operating Margin (MRQ)Greater than0-0.164
Quick Ratio (MRQ)Greater than14.210
Current Ratio (MRQ)Greater than15.726
Debt to Asset Ratio (MRQ)Less than10.221
Debt to Equity Ratio (MRQ)Less than10.284
Return on Equity (MRQ)Greater than0.15-0.033
Return on Assets (MRQ)Greater than0.05-0.026
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Anika Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.892
Ma 20Greater thanMa 5011.070
Ma 50Greater thanMa 10012.100
Ma 100Greater thanMa 20013.994
OpenGreater thanClose11.270
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide short-and long-term pain relief. The company's joint preservation and restoration product family comprises orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions. In addition, the company offers non-orthopedic products comprising HA-based products for Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier for use after abdominal-pelvic surgeries; and Hyalomatrix for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

Fundamental data was last updated by Penke on 2025-06-18 23:20:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Anika earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Anika to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -18.6% means that $-0.19 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anika Therapeutics Inc:

  • The MRQ is -18.6%. The company is making a huge loss. -2
  • The TTM is 399.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-18.6%TTM399.7%-418.4%
TTM399.7%YOY-44.9%+444.7%
TTM399.7%5Y63.6%+336.2%
5Y63.6%10Y44.4%+19.2%
4.3.1.2. Return on Assets

Shows how efficient Anika is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Anika to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.6% Return on Assets means that Anika generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anika Therapeutics Inc:

  • The MRQ is -2.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-6.6%+4.0%
TTM-6.6%YOY-7.0%+0.4%
TTM-6.6%5Y-3.4%-3.2%
5Y-3.4%10Y-0.3%-3.1%
4.3.1.3. Return on Equity

Shows how efficient Anika is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Anika to the Drug Manufacturers - Specialty & Generic industry mean.
  • -3.3% Return on Equity means Anika generated $-0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anika Therapeutics Inc:

  • The MRQ is -3.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.3%TTM-8.5%+5.3%
TTM-8.5%YOY-8.8%+0.3%
TTM-8.5%5Y-4.4%-4.2%
5Y-4.4%10Y-0.7%-3.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Anika Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Anika is operating .

  • Measures how much profit Anika makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Anika to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -16.4% means the company generated $-0.16  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anika Therapeutics Inc:

  • The MRQ is -16.4%. The company is operating very inefficient. -2
  • The TTM is -508.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-16.4%TTM-508.1%+491.8%
TTM-508.1%YOY-11.0%-497.1%
TTM-508.1%5Y-112.2%-396.0%
5Y-112.2%10Y-38.3%-73.8%
4.3.2.2. Operating Ratio

Measures how efficient Anika is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are $1.16 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anika Therapeutics Inc:

  • The MRQ is 1.164. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.612. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.164TTM6.612-5.448
TTM6.612YOY1.107+5.505
TTM6.6125Y2.234+4.377
5Y2.23410Y1.440+0.794
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Anika Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Anika is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 5.73 means the company has $5.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anika Therapeutics Inc:

  • The MRQ is 5.726. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.469. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.726TTM5.469+0.257
TTM5.469YOY5.730-0.261
TTM5.4695Y5.664-0.195
5Y5.66410Y10.874-5.209
4.4.3.2. Quick Ratio

Measures if Anika is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Anika to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 4.21 means the company can pay off $4.21 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anika Therapeutics Inc:

  • The MRQ is 4.210. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.716. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.210TTM3.716+0.493
TTM3.716YOY4.176-0.459
TTM3.7165Y4.596-0.880
5Y4.59610Y10.914-6.318
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Anika Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Anika assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Anika to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.22 means that Anika assets are financed with 22.1% credit (debt) and the remaining percentage (100% - 22.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Anika Therapeutics Inc:

  • The MRQ is 0.221. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.221. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.221TTM0.221+0.000
TTM0.221YOY0.192+0.029
TTM0.2215Y0.213+0.008
5Y0.21310Y0.154+0.059
4.5.4.2. Debt to Equity Ratio

Measures if Anika is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Anika to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 28.4% means that company has $0.28 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anika Therapeutics Inc:

  • The MRQ is 0.284. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.284. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.284TTM0.284+0.000
TTM0.284YOY0.238+0.046
TTM0.2845Y0.276+0.008
5Y0.27610Y0.192+0.084
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Anika generates.

  • Above 15 is considered overpriced but always compare Anika to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -11.06 means the investor is paying $-11.06 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anika Therapeutics Inc:

  • The EOD is -8.277. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.058. Based on the earnings, the company is expensive. -2
  • The TTM is -271.174. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.277MRQ-11.058+2.781
MRQ-11.058TTM-271.174+260.115
TTM-271.174YOY-16.791-254.383
TTM-271.1745Y-48.954-222.220
5Y-48.95410Y-14.874-34.079
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Anika Therapeutics Inc:

  • The EOD is -13.654. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -18.242. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 51.256. Based on how much money comes from the company's main activities, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD-13.654MRQ-18.242+4.588
MRQ-18.242TTM51.256-69.498
TTM51.256YOY-0.007+51.263
TTM51.2565Y33.230+18.025
5Y33.23010Y37.023-3.792
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Anika is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Anika Therapeutics Inc:

  • The EOD is 1.087. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.453. Based on the equity, the company is underpriced. +1
  • The TTM is 1.710. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.087MRQ1.453-0.365
MRQ1.453TTM1.710-0.258
TTM1.710YOY1.439+0.272
TTM1.7105Y1.679+0.031
5Y1.67910Y2.193-0.514
4.6.2. Total Gains per Share

2.4. Latest News of Anika Therapeutics Inc

Does Anika Therapeutics Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Anika Therapeutics Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-14
11:51
Validea Kenneth Fisher Strategy Daily Upgrade Report - 6/14/2025Read

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anika Therapeutics Inc.

4.8.1. Institutions holding Anika Therapeutics Inc

Institutions are holding 90.276% of the shares of Anika Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Trigran Investments Inc14.23754.51552041853200750.9929
2025-03-31BlackRock Inc10.59350.00051519261-38621-2.4791
2025-03-31Caligan Partners LP10.00694.501143513000
2025-03-31Vanguard Group Inc5.42070.0002777405121351.5857
2025-03-31Dimensional Fund Advisors, Inc.4.28110.0023613972-43383-6.5996
2025-03-31Acadian Asset Management LLC3.76260.0229539614539343199019.5572
2025-03-31BOOTHBAY FUND MANAGEMENT, LLC3.69210.209752950300
2025-03-31Renaissance Technologies Corp3.68590.0125286171000.0189
2025-03-31Alta Fundamental Advisers LLC3.2844.5507470974-229458-32.7595
2025-03-31Opaleye Management Inc2.75431.32183950003950000
2025-03-31Geode Capital Management, LLC2.3010.000432999872202.2368
2025-03-31Capital Management Corp2.29870.85832966041151.264
2025-03-31State Street Corp2.27740.0002326615123753.9381
2025-03-31Stonepine Capital Management Llc1.44093.1732206639-31583-13.2578
2025-03-31Meros Investment Management, LP1.20971.5311173489-4186-2.356
2024-12-31D. E. Shaw & Co LP1.07220.0019153764-297-0.1928
2025-03-31Charles Schwab Investment Management Inc1.04550.0004149935124739.0738
2025-03-31Jacobs Levy Equity Management, Inc.0.95020.00811362791730314.5433
2025-03-31Morgan Stanley - Brokerage Accounts0.87050.0001124836-64342-34.0114
2025-03-31Northern Trust Corp0.84240.0003120815-2383-1.9343
Total 76.027120.710310903359+605886+5.6%

4.9.2. Funds holding Anika Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv3.06390.000443941200
2025-05-31iShares Russell 2000 ETF2.08930.005429963500
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.6440.00342357809410.4007
2025-03-31CMC SMID1.51123.1725216730-10185-4.4885
2025-03-31Fidelity Small Cap Index0.89390.0081282056540.5127
2025-04-30DFA US Targeted Value I0.78330.013811233700
2025-05-31iShares Russell 2000 Value ETF0.66730.00999569700
2025-03-31CMC All-Cap Growth0.642.3611917801170014.6104
2025-05-30Dimensional US Targeted Value ETF0.62950.00999027800
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.62860.00249015700
2025-04-30DFA US Micro Cap I0.62010.02158893100
2025-04-30Fidelity Extended Market Index0.55730.003279919-764-0.9469
2025-05-31Schwab US Small-Cap ETF™0.47940.004668749-185-0.2684
2025-04-30Vanguard Russell 2000 ETF0.45720.00816556936195.8418
2025-04-30DFA US Small Cap I0.44870.006364355-1346-2.0487
2025-04-30Xtrackers S&P Global Infra Swap ETF 1C0.35480.22445088700
2025-05-31State St Russell Sm Cap® Indx SL Cl I0.33560.00624812700
2025-05-31iShares Core S&P Total US Stock Mkt ETF0.30530.00074378000
2025-03-31BlackRock Credit Strategies Instl0.29750.106342667737620.9005
2025-05-30Dimensional US Small Cap ETF0.27040.00443877700
Total 16.67735.97252391772+11810+0.5%

5.3. Insider Transactions

Insiders are holding 4.121% of the shares of Anika Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-05-11David ColleranBUY150021.37
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets190,605
Total Liabilities42,208
Total Stockholder Equity148,397
 As reported
Total Liabilities 42,208
Total Stockholder Equity+ 148,397
Total Assets = 190,605

Assets

Total Assets190,605
Total Current Assets102,509
Long-term Assets88,096
Total Current Assets
Cash And Cash Equivalents 53,371
Net Receivables 21,987
Inventory 21,336
Other Current Assets 5,815
Total Current Assets  (as reported)102,509
Total Current Assets  (calculated)102,509
+/-0
Long-term Assets
Property Plant Equipment 65,641
Goodwill 7,423
Intangible Assets 2,281
Long-term Assets Other 11,563
Long-term Assets  (as reported)88,096
Long-term Assets  (calculated)86,908
+/- 1,188

Liabilities & Shareholders' Equity

Total Current Liabilities17,901
Long-term Liabilities24,307
Total Stockholder Equity148,397
Total Current Liabilities
Short-term Debt 1,874
Accounts payable 5,277
Other Current Liabilities 10,685
Total Current Liabilities  (as reported)17,901
Total Current Liabilities  (calculated)17,836
+/- 65
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt23,563
Long-term Liabilities Other 744
Long-term Liabilities  (as reported)24,307
Long-term Liabilities  (calculated)24,307
+/-0
Total Stockholder Equity
Common Stock143
Retained Earnings 66,794
Accumulated Other Comprehensive Income -6,103
Other Stockholders Equity 87,563
Total Stockholder Equity (as reported)148,397
Total Stockholder Equity (calculated)148,397
+/-0
Other
Capital Stock143
Cash and Short Term Investments 53,371
Common Stock Shares Outstanding 14,297
Liabilities and Stockholders Equity 190,605
Net Debt -27,934
Net Invested Capital 148,397
Net Working Capital 84,608
Property Plant and Equipment Gross 113,287
Short Long Term Debt Total 25,437



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-311995-09-301995-06-301995-03-311994-12-311994-09-301994-06-301994-03-311993-12-311993-09-301993-06-301993-03-31
> Total Assets 
9,500
9,600
9,300
8,600
8,300
7,700
7,100
6,800
9,100
8,000
7,700
7,000
9,400
8,600
7,900
7,900
7,100
7,900
8,100
28,700
29,900
32,100
32,800
32,400
31,100
31,800
31,700
32,500
32,656
32,929
30,619
28,979
26,832
25,641
23,824
22,916
21,102
20,215
19,928
20,086
19,347
18,814
19,757
21,873
52,692
50,670
54,066
59,538
59,473
59,710
62,818
62,618
62,693
66,250
68,512
68,114
69,428
75,661
81,229
79,497
82,565
88,316
88,291
95,821
95,367
95,958
96,475
130,702
127,242
124,115
129,853
128,937
128,761
131,393
129,780
132,844
133,229
136,376
134,872
142,069
141,358
148,395
156,883
156,042
174,061
179,097
185,498
193,996
197,685
208,012
222,851
235,748
214,457
222,738
231,062
240,246
247,367
265,004
273,132
282,617
284,336
265,414
269,264
278,993
306,659
287,364
319,579
330,710
396,522
440,525
416,338
365,605
362,253
363,131
352,930
347,535
342,239
354,123
347,746
349,128
339,074
328,882
328,158
270,632
263,744
262,655
231,405
202,740
190,605
190,605202,740231,405262,655263,744270,632328,158328,882339,074349,128347,746354,123342,239347,535352,930363,131362,253365,605416,338440,525396,522330,710319,579287,364306,659278,993269,264265,414284,336282,617273,132265,004247,367240,246231,062222,738214,457235,748222,851208,012197,685193,996185,498179,097174,061156,042156,883148,395141,358142,069134,872136,376133,229132,844129,780131,393128,761128,937129,853124,115127,242130,70296,47595,95895,36795,82188,29188,31682,56579,49781,22975,66169,42868,11468,51266,25062,69362,61862,81859,71059,47359,53854,06650,67052,69221,87319,75718,81419,34720,08619,92820,21521,10222,91623,82425,64126,83228,97930,61932,92932,65632,50031,70031,80031,10032,40032,80032,10029,90028,7008,1007,9007,1007,9007,9008,6009,4007,0007,7008,0009,1006,8007,1007,7008,3008,6009,3009,6009,500
   > Total Current Assets 
5,800
8,100
7,800
7,200
6,800
6,300
5,800
5,600
7,900
6,600
6,200
5,400
7,900
7,300
6,700
6,700
6,200
7,100
7,300
27,800
28,300
29,700
30,100
29,500
28,000
22,800
22,100
22,900
23,186
28,987
26,846
25,349
23,293
21,992
20,262
19,568
18,010
17,449
17,404
17,944
17,357
17,035
18,256
20,539
42,971
41,243
44,012
49,083
49,061
49,151
52,467
52,410
52,138
55,089
57,261
57,606
58,077
62,297
61,171
52,443
50,231
50,182
48,928
55,830
54,901
55,051
55,112
49,805
49,778
51,510
54,147
56,322
55,033
57,485
58,648
64,138
63,953
69,599
68,402
77,384
78,695
86,474
95,003
94,592
113,485
119,517
128,656
139,025
145,921
155,726
168,284
176,433
147,900
154,644
161,074
170,440
177,050
192,881
199,034
206,327
208,187
190,991
195,591
202,943
209,695
189,924
223,817
235,747
160,591
221,283
201,875
177,383
173,474
177,761
165,780
168,528
165,322
167,856
167,761
169,547
160,331
152,201
156,778
163,309
158,962
155,000
136,106
113,652
102,509
102,509113,652136,106155,000158,962163,309156,778152,201160,331169,547167,761167,856165,322168,528165,780177,761173,474177,383201,875221,283160,591235,747223,817189,924209,695202,943195,591190,991208,187206,327199,034192,881177,050170,440161,074154,644147,900176,433168,284155,726145,921139,025128,656119,517113,48594,59295,00386,47478,69577,38468,40269,59963,95364,13858,64857,48555,03356,32254,14751,51049,77849,80555,11255,05154,90155,83048,92850,18250,23152,44361,17162,29758,07757,60657,26155,08952,13852,41052,46749,15149,06149,08344,01241,24342,97120,53918,25617,03517,35717,94417,40417,44918,01019,56820,26221,99223,29325,34926,84628,98723,18622,90022,10022,80028,00029,50030,10029,70028,30027,8007,3007,1006,2006,7006,7007,3007,9005,4006,2006,6007,9005,6005,8006,3006,8007,2007,8008,1005,800
       Cash And Cash Equivalents 
5,400
5,100
4,500
3,500
3,300
2,600
2,000
1,600
3,300
2,800
2,200
1,500
4,000
3,700
2,900
2,900
2,600
2,900
3,100
22,700
22,400
23,500
12,700
10,700
5,600
5,200
1,400
6,400
8,946
5,469
5,678
8,266
6,387
8,264
10,001
9,065
10,448
7,478
7,201
11,002
10,490
11,453
12,611
14,592
34,499
33,536
34,003
39,339
40,337
39,930
45,872
44,747
44,460
46,127
47,420
47,167
43,781
44,751
46,160
35,904
38,953
37,297
35,368
43,194
40,427
39,550
38,540
24,427
23,168
23,649
25,766
28,202
29,079
26,829
29,049
35,777
34,003
37,910
39,856
44,067
50,966
54,140
64,055
63,333
82,160
84,880
71,772
100,156
99,802
103,920
108,469
110,707
92,837
89,125
98,047
104,261
119,368
117,874
126,960
133,256
141,797
126,047
81,825
89,042
95,514
69,407
103,381
157,463
65,833
116,746
104,216
95,817
94,599
97,181
90,976
94,386
90,325
91,392
87,777
86,327
79,737
65,071
70,651
72,867
68,629
62,822
62,368
55,629
53,371
53,37155,62962,36862,82268,62972,86770,65165,07179,73786,32787,77791,39290,32594,38690,97697,18194,59995,817104,216116,74665,833157,463103,38169,40795,51489,04281,825126,047141,797133,256126,960117,874119,368104,26198,04789,12592,837110,707108,469103,92099,802100,15671,77284,88082,16063,33364,05554,14050,96644,06739,85637,91034,00335,77729,04926,82929,07928,20225,76623,64923,16824,42738,54039,55040,42743,19435,36837,29738,95335,90446,16044,75143,78147,16747,42046,12744,46044,74745,87239,93040,33739,33934,00333,53634,49914,59212,61111,45310,49011,0027,2017,47810,4489,06510,0018,2646,3878,2665,6785,4698,9466,4001,4005,2005,60010,70012,70023,50022,40022,7003,1002,9002,6002,9002,9003,7004,0001,5002,2002,8003,3001,6002,0002,6003,3003,5004,5005,1005,400
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,200
13,600
8,200
5,160
13,682
12,292
10,040
10,420
7,422
3,958
3,994
2,000
4,500
4,500
2,500
2,500
0
0
818
0
0
0
0
0
0
0
0
0
0
0
0
3,523
3,516
3,509
3,502
3,502
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
6,750
12,500
18,513
22,007
27,751
23,000
22,500
22,250
20,500
19,250
25,000
25,750
24,000
21,250
13,250
67,186
69,972
71,222
72,045
69,825
27,480
26,452
27,624
20,542
2,501
2,501
0
90,976
0
29,313
32,172
34,168
34,627
30,629
36,737
0
0
0
0
0
0
0
000000036,73730,62934,62734,16832,17229,313090,97602,5012,50120,54227,62426,45227,48069,82572,04571,22269,97267,18613,25021,25024,00025,75025,00019,25020,50022,25022,50023,00027,75122,00718,51312,5006,75020,00000000000000000000000000003,5023,5023,5093,5163,523000000000000818002,5002,5004,5004,5002,0003,9943,9587,42210,42010,04012,29213,6825,1608,20013,60010,2000000000000000000000000000
       Net Receivables 
0
300
500
600
200
200
400
200
500
200
500
600
600
600
900
900
700
1,200
1,000
1,900
2,700
2,700
2,300
3,000
2,300
2,800
2,400
2,100
1,812
2,116
1,850
1,692
1,252
1,206
2,003
2,241
2,053
2,229
2,303
1,198
948
2,105
1,909
1,421
2,975
1,693
3,075
2,354
2,558
2,744
1,567
2,066
2,240
2,768
2,748
3,510
3,007
6,751
4,966
5,796
3,290
5,932
6,530
5,418
6,483
6,456
7,982
11,779
12,707
15,061
14,730
14,820
12,488
17,020
17,727
17,308
17,003
17,694
16,344
21,462
14,784
19,065
16,497
18,737
16,466
19,235
20,170
17,152
16,025
19,166
23,376
21,652
14,798
24,597
21,833
27,598
21,079
30,450
23,804
23,825
18,289
23,389
20,771
20,775
18,265
23,073
23,889
23,079
28,101
24,094
23,009
24,102
26,509
29,426
32,352
29,843
29,313
32,172
34,168
34,627
30,629
36,737
34,682
35,961
32,077
33,773
28,357
23,594
21,987
21,98723,59428,35733,77332,07735,96134,68236,73730,62934,62734,16832,17229,31329,84332,35229,42626,50924,10223,00924,09428,10123,07923,88923,07318,26520,77520,77123,38918,28923,82523,80430,45021,07927,59821,83324,59714,79821,65223,37619,16616,02517,15220,17019,23516,46618,73716,49719,06514,78421,46216,34417,69417,00317,30817,72717,02012,48814,82014,73015,06112,70711,7797,9826,4566,4835,4186,5305,9323,2905,7964,9666,7513,0073,5102,7482,7682,2402,0661,5672,7442,5582,3543,0751,6932,9751,4211,9092,1059481,1982,3032,2292,0532,2412,0031,2061,2521,6921,8502,1161,8122,1002,4002,8002,3003,0002,3002,7002,7001,9001,0001,2007009009006006006005002005002004002002006005003000
       Other Current Assets 
400
100
100
200
200
100
100
100
500
300
300
200
0
500
0
300
400
600
500
700
400
700
11,800
12,300
16,600
600
500
700
475
486
460
613
457
475
365
540
343
456
624
320
245
249
394
899
1,875
2,265
2,768
3,163
2,402
2,440
1,683
2,327
1,937
1,760
1,489
1,533
1,782
1,741
1,824
2,851
2,619
2,170
1,989
1,699
2,094
1,740
1,639
5,077
5,118
4,430
4,256
4,351
4,692
4,465
3,998
3,750
3,866
3,219
3,270
3,571
2,997
3,831
2,868
1,525
1,876
1,538
3,131
2,560
5,078
2,408
2,356
1,385
1,500
1,158
924
2,098
1,173
1,973
2,268
3,211
4,081
4,244
1,981
1,854
2,077
2,413
1,479
4,289
5,659
6,340
6,226
8,754
19,296
16,594
14,866
16,578
20,918
17,912
17,158
17,656
8,646
7,789
7,721
8,095
8,848
6,941
5,752
10,620
5,815
5,81510,6205,7526,9418,8488,0957,7217,7898,64617,65617,15817,91220,91816,57814,86616,59419,2968,7546,2266,3405,6594,2891,4792,4132,0771,8541,9814,2444,0813,2112,2681,9731,1732,0989241,1581,5001,3852,3562,4085,0782,5603,1311,5381,8761,5252,8683,8312,9973,5713,2703,2193,8663,7503,9984,4654,6924,3514,2564,4305,1185,0771,6391,7402,0941,6991,9892,1702,6192,8511,8241,7411,7821,5331,4891,7601,9372,3271,6832,4402,4023,1632,7682,2651,87589939424924532062445634354036547545761346048647570050060016,60012,30011,80070040070050060040030005000200300300500100100100200200100100400
   > Long-term Assets 
3,700
1,500
1,500
1,400
1,500
1,400
1,300
1,200
1,200
1,400
1,500
1,600
1,500
1,300
1,200
1,200
900
800
800
900
1,600
2,400
2,700
2,900
3,100
9,000
9,600
9,600
9,470
3,941
3,773
0
3,539
3,650
3,562
3,348
3,092
2,766
2,524
2,143
1,990
1,779
1,501
1,334
9,721
9,427
10,054
10,455
10,412
10,559
10,351
10,208
10,555
11,161
11,250
10,508
11,352
13,365
20,058
27,054
32,334
38,134
39,364
39,990
40,465
40,907
41,362
80,897
77,464
72,605
75,707
72,615
73,729
73,907
71,133
68,707
69,276
66,777
66,470
64,685
62,663
61,921
61,880
61,450
60,577
59,580
56,842
54,971
51,764
52,287
54,567
59,315
66,557
68,094
69,988
69,806
70,317
72,123
74,098
76,290
76,149
74,423
73,673
76,050
96,964
97,440
95,762
96,404
235,931
219,242
214,463
188,222
188,779
185,370
187,150
179,007
176,917
186,267
179,985
179,581
178,743
176,681
171,380
107,323
104,782
107,655
95,299
89,088
88,096
88,09689,08895,299107,655104,782107,323171,380176,681178,743179,581179,985186,267176,917179,007187,150185,370188,779188,222214,463219,242235,93196,40495,76297,44096,96476,05073,67374,42376,14976,29074,09872,12370,31769,80669,98868,09466,55759,31554,56752,28751,76454,97156,84259,58060,57761,45061,88061,92162,66364,68566,47066,77769,27668,70771,13373,90773,72972,61575,70772,60577,46480,89741,36240,90740,46539,99039,36438,13432,33427,05420,05813,36511,35210,50811,25011,16110,55510,20810,35110,55910,41210,45510,0549,4279,7211,3341,5011,7791,9902,1432,5242,7663,0923,3483,5623,6503,53903,7733,9419,4709,6009,6009,0003,1002,9002,7002,4001,6009008008009001,2001,2001,3001,5001,6001,5001,4001,2001,2001,3001,4001,5001,4001,5001,5003,700
       Property Plant Equipment 
1,200
1,500
1,500
1,400
1,400
1,400
1,300
1,200
1,200
1,400
1,500
1,500
1,500
1,300
1,200
1,200
800
700
600
800
1,200
2,200
2,400
2,600
2,800
3,000
3,500
3,500
3,405
3,464
3,266
3,123
3,033
3,278
3,191
2,947
2,691
2,445
2,202
1,941
1,788
1,577
1,358
1,191
1,175
1,082
1,093
955
912
1,059
1,695
2,096
2,375
2,925
2,966
3,018
3,515
5,481
12,184
19,370
24,393
30,084
31,327
32,247
32,972
33,346
33,732
35,748
36,003
35,994
36,420
36,981
36,780
36,885
36,695
36,470
36,674
36,421
35,937
35,113
34,479
33,847
33,262
32,939
32,634
32,388
32,037
31,669
31,190
31,523
33,797
40,108
46,839
49,198
51,058
52,296
51,593
52,272
53,973
56,183
55,772
55,377
55,041
54,111
76,799
76,455
74,832
73,647
77,760
75,855
74,527
73,232
71,456
71,389
70,508
68,559
68,471
79,694
78,377
78,975
78,978
77,619
74,990
74,965
74,238
75,450
71,780
64,679
65,641
65,64164,67971,78075,45074,23874,96574,99077,61978,97878,97578,37779,69468,47168,55970,50871,38971,45673,23274,52775,85577,76073,64774,83276,45576,79954,11155,04155,37755,77256,18353,97352,27251,59352,29651,05849,19846,83940,10833,79731,52331,19031,66932,03732,38832,63432,93933,26233,84734,47935,11335,93736,42136,67436,47036,69536,88536,78036,98136,42035,99436,00335,74833,73233,34632,97232,24731,32730,08424,39319,37012,1845,4813,5153,0182,9662,9252,3752,0961,6951,0599129551,0931,0821,1751,1911,3581,5771,7881,9412,2022,4452,6912,9473,1913,2783,0333,1233,2663,4643,4053,5003,5003,0002,8002,6002,4002,2001,2008006007008001,2001,2001,3001,5001,5001,5001,4001,2001,2001,3001,4001,4001,4001,5001,5001,200
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,721
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
995
980
966
951
936
922
907
892
7,652
7,183
6,269
6,990
9,092
9,672
9,872
9,328
8,883
9,150
8,628
8,819
9,066
8,792
8,923
9,275
9,444
9,434
9,361
8,702
8,339
7,443
7,611
7,713
7,482
7,790
7,568
7,690
7,214
7,328
7,836
8,104
8,218
8,452
8,013
7,959
7,851
7,695
7,798
7,489
7,694
31,946
33,958
32,419
8,413
8,045
8,149
7,950
7,781
7,625
7,169
6,721
7,339
7,462
7,467
7,253
7,571
7,403
7,350
7,656
7,125
7,423
7,4237,1257,6567,3507,4037,5717,2537,4677,4627,3396,7217,1697,6257,7817,9508,1498,0458,41332,41933,95831,9467,6947,4897,7987,6957,8517,9598,0138,4528,2188,1047,8367,3287,2147,6907,5687,7907,4827,7137,6117,4438,3398,7029,3619,4349,4449,2758,9238,7929,0668,8198,6289,1508,8839,3289,8729,6729,0926,9906,2697,1837,6528929079229369519669809950000000000000000000000006,7210000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
76,545
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
995
980
966
951
936
922
907
892
33,577
31,059
27,790
30,375
25,764
26,806
26,782
24,810
23,149
23,300
21,506
21,464
20,335
19,230
18,997
19,197
18,998
18,439
17,762
16,034
14,895
13,061
13,084
12,988
11,656
11,859
11,259
11,171
10,227
10,162
10,626
10,738
10,635
10,678
9,876
9,564
9,191
8,467
8,303
7,680
7,585
98,718
95,978
94,291
91,157
88,986
87,084
85,021
82,382
80,436
78,490
76,545
74,599
72,653
70,707
68,762
4,626
4,297
3,969
3,081
2,490
2,281
2,2812,4903,0813,9694,2974,62668,76270,70772,65374,59976,54578,49080,43682,38285,02187,08488,98691,15794,29195,97898,7187,5857,6808,3038,4679,1919,5649,87610,67810,63510,73810,62610,16210,22711,17111,25911,85911,65612,98813,08413,06114,89516,03417,76218,43918,99819,19718,99719,23020,33521,46421,50623,30023,14924,81026,78226,80625,76430,37527,79031,05933,57789290792293695196698099500000000000000000000000076,5450000000000000000000000000000000000
       Long-term Assets Other 
2,500
0
0
0
100
0
0
0
0
0
0
100
0
0
0
100
100
100
200
100
400
200
300
300
300
6,000
6,100
6,100
6,065
478
507
507
506
372
-82,894
401
401
321
321
202
202
202
143
143
143
143
143
143
143
143
143
143
143
143
143
193
399
399
349
433
598
592
561
0
358
351
0
413
413
0
0
385
-1,890
-1,991
-1,991
205
-1,919
-1,919
-1,919
171
163
154
146
69
69
69
69
69
69
69
69
69
69
69
69
69
1,234
1,389
1,283
1,254
1,247
1,157
1,109
4,897
4,003
4,884
5,761
7,478
27,507
13,451
13,226
15,420
20,292
18,748
23,671
2,513
20,385
20,914
18,342
17,219
18,131
19,390
18,951
14,046
17,571
19,524
11,310
13,617
11,563
11,56313,61711,31019,52417,57114,04618,95119,39018,13117,21918,34220,91420,3852,51323,67118,74820,29215,42013,22613,45127,5077,4785,7614,8844,0034,8971,1091,1571,2471,2541,2831,3891,23469696969696969696969696969146154163171-1,919-1,919-1,919205-1,991-1,991-1,8903850041341303513580561592598433349399399193143143143143143143143143143143143143143202202202321321401401-82,8943725065075074786,0656,1006,1006,0003003003002004001002001001001000001000000001000002,500
> Total Liabilities 
2,200
2,900
2,700
2,200
2,400
2,300
2,100
2,000
2,500
2,200
2,300
2,500
1,700
1,700
1,600
1,600
1,600
2,000
2,200
2,500
2,300
2,100
2,000
2,500
2,700
2,400
2,200
6,800
7,335
7,311
6,316
2,266
2,365
3,770
3,269
2,812
2,803
3,073
3,523
3,023
2,596
2,135
2,603
3,889
26,916
23,840
26,180
29,175
27,636
25,202
25,757
24,726
22,983
24,603
24,569
22,626
21,876
25,318
28,606
24,536
26,087
30,514
29,016
35,064
34,042
33,416
32,145
48,558
45,961
44,293
45,475
43,747
41,150
40,259
36,927
38,082
34,968
35,627
31,399
33,144
28,530
28,961
28,676
20,408
17,491
16,702
15,793
15,899
15,869
17,445
23,096
24,900
19,089
18,322
16,519
17,473
17,339
20,866
19,843
19,126
20,570
18,811
13,999
15,381
37,588
36,418
37,897
42,332
105,160
152,081
131,887
93,205
85,597
76,327
62,870
60,450
56,452
67,970
62,809
63,565
61,486
54,867
57,672
58,367
55,208
52,317
51,541
48,751
42,208
42,20848,75151,54152,31755,20858,36757,67254,86761,48663,56562,80967,97056,45260,45062,87076,32785,59793,205131,887152,081105,16042,33237,89736,41837,58815,38113,99918,81120,57019,12619,84320,86617,33917,47316,51918,32219,08924,90023,09617,44515,86915,89915,79316,70217,49120,40828,67628,96128,53033,14431,39935,62734,96838,08236,92740,25941,15043,74745,47544,29345,96148,55832,14533,41634,04235,06429,01630,51426,08724,53628,60625,31821,87622,62624,56924,60322,98324,72625,75725,20227,63629,17526,18023,84026,9163,8892,6032,1352,5963,0233,5233,0732,8032,8123,2693,7702,3652,2666,3167,3117,3356,8002,2002,4002,7002,5002,0002,1002,3002,5002,2002,0001,6001,6001,6001,7001,7002,5002,3002,2002,5002,0002,1002,3002,4002,2002,7002,9002,200
   > Total Current Liabilities 
400
1,300
1,100
600
800
800
600
500
1,900
1,700
1,800
1,900
1,600
1,400
1,500
1,500
1,500
1,800
2,100
2,400
2,100
2,100
2,000
2,400
2,700
2,400
2,200
4,000
4,610
4,661
6,316
2,266
2,365
3,770
3,269
2,812
2,803
3,073
3,523
3,023
2,596
2,135
2,603
2,089
7,666
5,140
5,994
6,948
6,164
4,951
6,182
5,826
4,758
6,091
6,756
5,461
5,252
7,513
10,181
10,637
8,841
10,094
9,412
9,033
9,025
9,486
9,230
16,535
15,979
16,499
18,330
19,370
18,037
17,382
15,139
14,538
12,880
15,214
12,155
14,453
10,741
11,701
10,357
9,283
7,712
7,321
6,434
5,973
6,157
7,957
13,245
17,278
10,865
10,523
7,589
8,799
10,217
13,441
11,705
13,073
14,122
12,533
9,305
11,289
11,602
10,388
11,195
16,277
26,811
27,907
31,139
36,867
46,973
41,367
28,771
29,795
26,992
29,431
26,352
27,914
28,693
23,456
28,064
31,059
28,460
26,121
25,493
23,306
17,901
17,90123,30625,49326,12128,46031,05928,06423,45628,69327,91426,35229,43126,99229,79528,77141,36746,97336,86731,13927,90726,81116,27711,19510,38811,60211,2899,30512,53314,12213,07311,70513,44110,2178,7997,58910,52310,86517,27813,2457,9576,1575,9736,4347,3217,7129,28310,35711,70110,74114,45312,15515,21412,88014,53815,13917,38218,03719,37018,33016,49915,97916,5359,2309,4869,0259,0339,41210,0948,84110,63710,1817,5135,2525,4616,7566,0914,7585,8266,1824,9516,1646,9485,9945,1407,6662,0892,6032,1352,5963,0233,5233,0732,8032,8123,2693,7702,3652,2666,3164,6614,6104,0002,2002,4002,7002,4002,0002,1002,1002,4002,1001,8001,5001,5001,5001,4001,6001,9001,8001,7001,9005006008008006001,1001,300400
       Short-term Debt 
0
0
0
0
0
0
0
0
1,000
1,000
1,000
1,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,703
0
0
0
1,297
1,095
0
0
0
0
0
0
0
0
1,583
1,751
1,574
1,115
1,497
2,355
2,760
100
400
600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
1,600
0
0
0
0
0
0
0
0
66
63
56
59
48
0
0
0
0
0
0
0
0
1,075
1,101
1,109
1,141
1,695
1,662
1,626
1,585
1,636
1,524
1,542
1,714
1,650
1,874
1,922
2,073
2,105
2,085
2,054
2,133
4,322
2,287
2,292
1,918
1,874
1,8741,9182,2922,2874,3222,1332,0542,0852,1052,0731,9221,8741,6501,7141,5421,5241,6361,5851,6261,6621,6951,1411,1091,1011,075000000004859566366000000001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6006004001002,7602,3551,4971,1151,5741,7511,583000000001,0951,2970001,7030000000000000000000000000001,0001,0001,0001,00000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,075
1,101
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000001,1011,07500000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
300
1,000
800
300
500
500
400
300
500
400
500
600
0
600
0
600
700
500
800
1,000
700
900
700
900
1,300
800
700
600
421
1,309
478
871
774
1,652
881
955
703
766
777
845
719
406
428
349
805
587
836
791
786
381
1,656
1,278
789
1,042
785
965
1,091
2,616
4,185
4,867
1,564
3,147
2,736
2,375
2,036
1,769
1,221
6,355
7,014
7,414
9,165
9,694
9,162
7,587
3,837
4,300
3,881
3,941
1,908
2,342
2,697
2,700
2,137
2,794
2,743
2,198
1,168
1,201
1,775
1,658
2,221
8,302
3,263
3,294
1,949
2,303
6,050
5,465
5,189
6,747
6,159
5,073
2,462
3,143
3,571
2,287
2,702
3,832
9,906
6,162
6,800
8,984
8,683
8,101
7,942
7,633
7,444
8,165
8,353
9,074
8,948
7,944
7,432
9,860
10,022
9,994
6,805
5,617
5,277
5,2775,6176,8059,99410,0229,8607,4327,9448,9489,0748,3538,1657,4447,6337,9428,1018,6838,9846,8006,1629,9063,8322,7022,2873,5713,1432,4625,0736,1596,7475,1895,4656,0502,3031,9493,2943,2638,3022,2211,6581,7751,2011,1682,1982,7432,7942,1372,7002,6972,3421,9083,9413,8814,3003,8377,5879,1629,6949,1657,4147,0146,3551,2211,7692,0362,3752,7363,1471,5644,8674,1852,6161,0919657851,0427891,2781,6563817867918365878053494284067198457777667039558811,6527748714781,3094216007008001,3009007009007001,000800500700600060006005004005003004005005003008001,000300
       Other Current Liabilities 
100
300
300
300
300
300
200
200
400
300
300
300
0
800
0
900
800
1,300
1,300
1,400
1,400
1,200
1,300
1,500
1,400
1,600
1,500
3,400
4,188
3,352
5,838
1,395
1,591
1,881
1,986
1,842
1,697
1,741
1,786
2,031
1,548
1,003
1,145
-63,638
1,095
1,433
1,587
2,041
1,586
1,458
1,704
1,718
1,201
-572,355
-1,320,188
-15,662
-144,685
-262,496
-380,598
-200,990
4,087
3,436
2,769
2,325
2,613
3,152
3,286
5,828
4,665
4,785
4,865
5,376
4,568
5,487
5,537
5,322
4,297
4,276
4,389
5,837
4,253
4,504
5,228
5,718
4,498
4,875
3,910
-407,529
1,688
4,442
6,548
8,976
7,602
7,229
5,640
6,496
4,167
5,673
6,516
6,326
7,963
7,385
6,791
7,761
5,660
6,243
6,618
11,304
14,587
20,083
22,713
26,298
36,654
31,742
19,287
20,448
17,898
19,392
16,077
15,957
16,751
12,496
17,759
17,826
13,329
13,763
16,314
15,708
10,685
10,68515,70816,31413,76313,32917,82617,75912,49616,75115,95716,07719,39217,89820,44819,28731,74236,65426,29822,71320,08314,58711,3046,6186,2435,6607,7616,7917,3857,9636,3266,5165,6734,1676,4965,6407,2297,6028,9766,5484,4421,688-407,5293,9104,8754,4985,7185,2284,5044,2535,8374,3894,2764,2975,3225,5375,4874,5685,3764,8654,7854,6655,8283,2863,1522,6132,3252,7693,4364,087-200,990-380,598-262,496-144,685-15,662-1,320,188-572,3551,2011,7181,7041,4581,5862,0411,5871,4331,095-63,6381,1451,0031,5482,0311,7861,7411,6971,8421,9861,8811,5911,3955,8383,3524,1883,4001,5001,6001,4001,5001,3001,2001,4001,4001,3001,30080090008000300300300400200200300300300300300100
   > Long-term Liabilities 
1,800
1,600
1,600
1,600
1,600
1,500
1,500
1,500
600
500
500
600
100
300
100
100
100
200
100
100
200
900
700
100
1,300
100
700
2,800
2,725
2,650
478
0
774
1,889
1,283
970
1,105
1,332
1,737
993
1,048
1,132
1,458
1,800
19,250
18,700
20,186
22,227
21,472
20,251
19,575
18,900
18,225
18,512
17,813
17,164
16,624
17,805
18,426
13,898
17,246
20,420
19,604
26,031
25,017
23,930
22,915
32,023
29,982
27,794
27,146
24,377
23,112
22,877
21,788
23,543
22,088
20,413
19,244
18,691
17,789
17,259
18,319
11,125
9,779
9,381
9,359
9,926
9,712
9,487
9,852
7,622
8,224
7,799
8,930
8,674
7,122
7,425
8,138
6,053
6,448
6,278
4,694
4,092
25,986
26,030
26,702
26,055
78,349
124,174
100,748
56,338
38,624
34,960
34,099
30,655
29,460
38,539
36,457
35,651
32,793
31,411
29,608
27,308
26,748
26,196
26,048
25,445
24,307
24,30725,44526,04826,19626,74827,30829,60831,41132,79335,65136,45738,53929,46030,65534,09934,96038,62456,338100,748124,17478,34926,05526,70226,03025,9864,0924,6946,2786,4486,0538,1387,4257,1228,6748,9307,7998,2247,6229,8529,4879,7129,9269,3599,3819,77911,12518,31917,25917,78918,69119,24420,41322,08823,54321,78822,87723,11224,37727,14627,79429,98232,02322,91523,93025,01726,03119,60420,42017,24613,89818,42617,80516,62417,16417,81318,51218,22518,90019,57520,25121,47222,22720,18618,70019,2501,8001,4581,1321,0489931,7371,3321,1059701,2831,88977404782,6502,7252,8007001001,3001007009002001001002001001001003001006005005006001,5001,5001,5001,6001,6001,6001,6001,800
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,400
10,000
9,600
9,200
8,800
8,400
8,000
7,600
7,200
6,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
25,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000025,00050,000000000000000000000000000006,8007,2007,6008,0008,4008,8009,2009,60010,00010,4000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,725
2,650
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
19,250
18,700
20,186
22,227
21,472
20,250
19,575
18,900
18,225
18,512
17,813
17,165
16,624
17,805
18,425
13,899
13,346
12,820
12,204
11,631
11,017
10,330
9,715
9,918
9,245
8,369
7,700
6,960
6,300
6,416
4,929
6,568
5,859
5,121
4,409
3,694
3,405
3,333
3,200
3,188
1,162
1,104
1,006
996
915
854
878
847
802
1,229
2,615
2,126
400
422
545
660
6,448
6,278
4,694
4,092
3,754
4,056
5,099
4,688
56,832
52,331
54,224
35,459
18,081
14,880
14,461
11,415
10,640
8,807
7,274
6,834
0
3,636
0
0
0
0
0
0
0
00000003,63606,8347,2748,80710,64011,41514,46114,88018,08135,45954,22452,33156,8324,6885,0994,0563,7544,0924,6946,2786,4486605454224002,1262,6151,2298028478788549159961,0061,1041,1623,1883,2003,3333,4053,6944,4095,1215,8596,5684,9296,4166,3006,9607,7008,3699,2459,9189,71510,33011,01711,63112,20412,82013,34613,89918,42517,80516,62417,16517,81318,51218,22518,90019,57520,25021,47222,22720,18618,70019,2501,80000000000000002,6502,7250000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,111
10,234
12,395
11,331
10,078
9,305
9,150
8,895
8,795
10,347
9,992
8,690
8,350
8,410
9,032
8,883
8,708
9,048
6,841
7,485
6,626
6,374
6,596
6,722
7,003
7,593
5,393
5,298
5,396
4,120
3,542
3,388
3,683
4,727
4,331
16,030
14,855
12,584
11,895
10,738
13,100
12,972
10,157
9,956
8,220
6,800
6,436
4,114
3,235
0
0
0
0
0
0
0
00000003,2354,1146,4366,8008,2209,95610,15712,97213,10010,73811,89512,58414,85516,0304,3314,7273,6833,3883,5424,1205,3965,2985,3937,5937,0036,7226,5966,3746,6267,4856,8419,0488,7088,8839,0328,4108,3508,6909,99210,3478,7958,8959,1509,30510,07811,33112,39510,23410,1110000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
7,300
6,700
6,600
6,400
5,900
5,400
5,000
4,800
6,600
5,800
5,400
4,500
0
6,900
0
6,300
5,500
5,900
5,900
26,200
27,600
30,000
30,800
29,900
28,400
29,400
29,500
25,700
25,321
25,618
24,303
26,713
24,467
21,871
20,555
20,104
18,300
17,142
16,405
17,064
16,751
16,679
17,154
17,984
25,776
26,830
27,886
30,363
31,837
34,508
37,061
37,892
39,710
41,648
43,942
45,488
47,552
50,344
52,623
54,961
56,478
57,803
59,275
60,757
61,325
62,542
64,330
82,144
81,281
79,822
84,378
85,190
87,612
91,134
92,853
94,763
98,261
100,748
103,473
108,925
112,828
119,434
128,206
135,634
156,570
162,394
169,705
178,097
181,816
190,567
199,754
210,848
195,368
204,416
214,543
222,773
230,028
244,138
253,289
263,491
263,766
246,603
255,265
263,612
269,071
250,946
281,682
288,378
291,362
288,444
284,451
272,400
276,656
286,804
290,060
287,085
285,787
286,153
284,937
285,563
277,588
274,015
270,486
212,265
208,536
210,338
179,864
153,989
148,397
148,397153,989179,864210,338208,536212,265270,486274,015277,588285,563284,937286,153285,787287,085290,060286,804276,656272,400284,451288,444291,362288,378281,682250,946269,071263,612255,265246,603263,766263,491253,289244,138230,028222,773214,543204,416195,368210,848199,754190,567181,816178,097169,705162,394156,570135,634128,206119,434112,828108,925103,473100,74898,26194,76392,85391,13487,61285,19084,37879,82281,28182,14464,33062,54261,32560,75759,27557,80356,47854,96152,62350,34447,55245,48843,94241,64839,71037,89237,06134,50831,83730,36327,88626,83025,77617,98417,15416,67916,75117,06416,40517,14218,30020,10420,55521,87124,46726,71324,30325,61825,32125,70029,50029,40028,40029,90030,80030,00027,60026,2005,9005,9005,5006,30006,90004,5005,4005,8006,6004,8005,0005,4005,9006,4006,6006,7007,300
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
100
101
102
103
103
105
105
105
106
106
107
108
109
111
112
112
113
114
114
114
114
114
114
134
135
135
135
135
135
136
136
136
138
138
138
139
140
140
143
143
146
148
148
149
150
150
150
150
148
148
146
146
146
146
146
147
147
146
142
142
142
138
143
143
142
142
142
143
144
144
144
144
145
146
146
146
147
147
146
147
148
148
147
144
143
1431441471481481471461471471461461461451441441441441431421421421431431381421421421461471471461461461461461481481501501501501491481481461431431401401391381381381361361361351351351351351341141141141141141141131121121111091081071061061051051051031031021011001001001001001001001001001001001001001001001001001001001000000000000000000000000000
   Retained Earnings 
100
-500
-600
-800
-1,300
-1,900
-2,300
-2,500
-3,000
-3,900
-4,400
-5,300
-5,800
-6,700
-7,600
-7,600
-9,200
-8,800
-9,100
-6,000
-5,400
-3,200
-2,400
-1,700
-1,300
-900
-900
-4,800
-5,337
-5,555
-6,938
-4,599
-6,917
-9,568
-10,900
-11,357
-13,161
-14,318
-15,056
-14,397
-14,709
-14,790
-14,370
-13,569
-5,783
-5,018
-4,134
-2,379
-1,177
160
2,692
3,514
4,394
5,746
7,071
8,118
9,318
10,683
12,479
14,153
14,770
15,583
16,687
17,782
18,305
19,260
20,772
21,470
22,184
23,251
24,435
25,786
26,110
28,393
31,369
34,252
36,164
39,901
41,546
46,010
49,078
54,973
59,930
66,584
81,614
90,917
97,088
104,904
108,419
116,239
124,619
135,662
142,557
151,172
160,124
168,209
173,188
184,557
191,444
199,511
192,825
202,916
210,515
218,233
222,740
232,175
241,375
245,426
248,887
243,511
237,100
221,444
224,282
230,813
231,371
225,578
222,645
219,802
215,627
210,719
200,369
197,628
191,052
128,052
123,538
123,450
93,532
71,667
66,794
66,79471,66793,532123,450123,538128,052191,052197,628200,369210,719215,627219,802222,645225,578231,371230,813224,282221,444237,100243,511248,887245,426241,375232,175222,740218,233210,515202,916192,825199,511191,444184,557173,188168,209160,124151,172142,557135,662124,619116,239108,419104,90497,08890,91781,61466,58459,93054,97349,07846,01041,54639,90136,16434,25231,36928,39326,11025,78624,43523,25122,18421,47020,77219,26018,30517,78216,68715,58314,77014,15312,47910,6839,3188,1187,0715,7464,3943,5142,692160-1,177-2,379-4,134-5,018-5,783-13,569-14,370-14,790-14,709-14,397-15,056-14,318-13,161-11,357-10,900-9,568-6,917-4,599-6,938-5,555-5,337-4,800-900-900-1,300-1,700-2,400-3,200-5,400-6,000-9,100-8,800-9,200-7,600-7,600-6,700-5,800-5,300-4,400-3,900-3,000-2,500-2,300-1,900-1,300-800-600-500100
   Accumulated Other Comprehensive Income -6,103-6,783-5,701-6,416-6,315-5,943-6,564-6,157-6,171-6,443-7,497-6,646-5,799-5,718-5,319-4,852-5,051-4,542-5,296-5,818-6,027-5,898-6,318-5,696-5,841-5,526-5,228-5,115-4,164-4,784-5,047-5,736-7,025-7,317-6,101-6,410-5,873-6,649-6,067-6,326-6,744-4,495-3,595-1,916-1,725-1,699-2,148-3,064-3,404-2,655-3,353-3,911-2,311-3,067-1,779-203-798-2,548-1,797-4,879-2,059-11,425-11,144-10,829-10,509-10,190-9,852-9,442-9,082-8,732-10,756-10,574-10,399-10,237-10,147-10,057-9,940-9,853-9,738-9,616-9,502-9,394-9,202-9,021-8,849-8,684-8,427-8,175-7,927-7,678-7,403-7,127-6,854-6,583-5-21-171-5,498-315-385-475-600-700-800-4,000-3,800-3,700-3,600-3,400-3,300-3,200-3,200-3,100-3,000-3,600-3,500-3,200-3,100-3,000-2,900-2,900-2,800-2,700-2,600-2,600-2,500-2,400-2,400-1,200
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
62,808
63,127
63,441
64,269
64,621
65,142
65,431
67,015
67,385
70,281
70,606
76,535
73,245
76,064
77,540
79,990
80,505
81,052
81,685
58,536
59,506
60,374
61,735
63,719
65,171
66,746
68,617
74,958
48,656
49,836
50,763
52,030
24,329
46,482
48,707
48,360
50,609
52,505
55,355
57,281
60,699
63,864
67,081
68,796
72,851
76,661
81,141
83,243
82,397
0
0
0
0
0
0
0
000000082,39783,24381,14176,66172,85168,79667,08163,86460,69957,28155,35552,50550,60948,36048,70746,48224,32952,03050,76349,83648,65674,95868,61766,74665,17163,71961,73560,37459,50658,53681,68581,05280,50579,99077,54076,06473,24576,53570,60670,28167,38567,01565,43165,14264,62164,26963,44163,12762,8080000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000-7-27-148-244-280-280-280-280-280-280-280-280-280-280-280-280-7970000000000000000000000000000
   Other Stockholders Equity 
8,400
9,600
9,600
9,700
9,800
9,900
10,000
10,100
10,200
10,300
7,400
7,400
0
11,100
0
11,300
15,100
15,200
15,500
35,500
36,400
36,800
36,900
32,600
33,700
31,000
31,000
31,000
31,033
31,457
31,456
0
31,456
31,360
31,360
31,360
31,360
31,360
31,360
31,361
31,360
31,369
31,424
31,453
31,459
31,747
31,918
32,639
32,911
34,243
34,264
-3,476,214
35,210
35,795
-7,026,933
-8,072,150
-9,270,864
-10,632,926
-12,426,877
-14,097,935
41,594
42,106
42,474
-17,721,336
42,906
43,167
43,443
-21,387,537
61,022
61,315
61,605
-25,697,938
62,165
62,808
63,127
-34,154,527
64,269
64,621
65,142
65,431
67,015
67,385
70,281
70,606
76,535
73,245
76,064
77,540
79,990
80,505
81,052
81,685
58,536
59,506
60,374
61,735
63,719
65,171
66,746
68,617
74,958
48,656
49,836
50,763
52,030
24,329
46,482
48,707
48,360
50,609
52,505
55,355
57,281
60,699
63,864
67,081
68,796
72,851
76,661
81,141
83,243
82,397
85,852
90,009
91,165
93,156
91,886
88,961
87,563
87,56388,96191,88693,15691,16590,00985,85282,39783,24381,14176,66172,85168,79667,08163,86460,69957,28155,35552,50550,60948,36048,70746,48224,32952,03050,76349,83648,65674,95868,61766,74665,17163,71961,73560,37459,50658,53681,68581,05280,50579,99077,54076,06473,24576,53570,60670,28167,38567,01565,43165,14264,62164,269-34,154,52763,12762,80862,165-25,697,93861,60561,31561,022-21,387,53743,44343,16742,906-17,721,33642,47442,10641,594-14,097,935-12,426,877-10,632,926-9,270,864-8,072,150-7,026,93335,79535,210-3,476,21434,26434,24332,91132,63931,91831,74731,45931,45331,42431,36931,36031,36131,36031,36031,36031,36031,36031,36031,456031,45631,45731,03331,00031,00031,00033,70032,60036,90036,80036,40035,50015,50015,20015,10011,300011,10007,4007,40010,30010,20010,10010,0009,9009,8009,7009,6009,6008,400



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue119,907
Cost of Revenue-43,909
Gross Profit75,99875,998
 
Operating Income (+$)
Gross Profit75,998
Operating Expense-81,099
Operating Income-5,101-5,101
 
Operating Expense (+$)
Research Development25,544
Selling General Administrative55,555
Selling And Marketing Expenses0
Operating Expense81,09981,099
 
Net Interest Income (+$)
Interest Income0
Interest Expense-2,337
Other Finance Cost-4,674
Net Interest Income2,337
 
Pretax Income (+$)
Operating Income-5,101
Net Interest Income2,337
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,764-7,438
EBIT - interestExpense = -7,438
-50,321
-54,048
Interest Expense2,337
Earnings Before Interest and Taxes (EBIT)-5,101-427
Earnings Before Interest and Taxes (EBITDA)3,020
 
After tax Income (+$)
Income Before Tax-2,764
Tax Provision-6,064
Net Income From Continuing Ops-8,828-8,828
Net Income-56,385
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses125,008
Total Other Income/Expenses Net2,337-2,337
 

Technical Analysis of Anika
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Anika. The general trend of Anika is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Anika's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Anika Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Anika Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 11.43 < 11.92 < 12.83.

The bearish price targets are: 10.47.

Know someone who trades $ANIK? Share this with them.👇

Anika Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Anika Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Anika Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Anika Therapeutics Inc. The current macd is -0.29140757.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Anika price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Anika. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Anika price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Anika Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAnika Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Anika Therapeutics Inc. The current adx is 34.26.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Anika shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Anika Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Anika Therapeutics Inc. The current sar is 10.48.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Anika Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Anika Therapeutics Inc. The current rsi is 48.89. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Anika Therapeutics Inc Daily Relative Strength Index (RSI) ChartAnika Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Anika Therapeutics Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Anika price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Anika Therapeutics Inc Daily Stochastic Oscillator ChartAnika Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Anika Therapeutics Inc. The current cci is 35.47.

Anika Therapeutics Inc Daily Commodity Channel Index (CCI) ChartAnika Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Anika Therapeutics Inc. The current cmo is 9.76061202.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Anika Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartAnika Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Anika Therapeutics Inc. The current willr is -21.6080402.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Anika is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Anika Therapeutics Inc Daily Williams %R ChartAnika Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Anika Therapeutics Inc.

Anika Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Anika Therapeutics Inc. The current atr is 0.51004254.

Anika Therapeutics Inc Daily Average True Range (ATR) ChartAnika Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Anika Therapeutics Inc. The current obv is -5,042,999.

Anika Therapeutics Inc Daily On-Balance Volume (OBV) ChartAnika Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Anika Therapeutics Inc. The current mfi is 61.09.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Anika Therapeutics Inc Daily Money Flow Index (MFI) ChartAnika Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Anika Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Anika Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Anika Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.892
Ma 20Greater thanMa 5011.070
Ma 50Greater thanMa 10012.100
Ma 100Greater thanMa 20013.994
OpenGreater thanClose11.270
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Anika with someone you think should read this too:
  • Are you bullish or bearish on Anika? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Anika? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Anika Therapeutics Inc

I send you an email if I find something interesting about Anika Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Anika Therapeutics Inc.

Receive notifications about Anika Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.